Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the audited standalone and ....
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Ltd has informed BSE and NSE that a meeting of its Board of Directors is scheduled for May 21, 2026. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board will also consider dividend recommendations alongside other routine matters. The company has confirmed that its trading window has been closed since April 1, 2026, and will reopen 48 hours after the financial results are declared. This is a routine pre-result disclosure filed under SEBI Listing Regulations.
This is a standard procedural filing ahead of the annual results announcement. Investors should note that the trading window remains closed for insiders until 48 hours after results are declared.